Filter
2938
Filtered Results: 2938
Text search:
M.
tuberculosis
Featured
Recommendations
266
New Publications
665
Language
Document type
No document type
1740
Studies & Reports
527
Guidelines
356
Manuals
125
Strategic & Response Plan
86
Training Material
40
Fact sheets
30
Situation Updates
17
Resource Platforms
6
Infographics
6
Brochures
4
Videos
1
Countries / Regions
India
117
Global
109
Western and Central Europe
92
South Africa
81
Kenya
66
Latin America and the Carribbean
53
Nepal
49
Ethiopia
49
Nigeria
48
Malawi
48
Tanzania
48
Eastern Europe
48
Uganda
47
Africa
43
Bangladesh
39
Germany
37
Myanmar / Burma
36
Rwanda
33
Zambia
33
Colombia
30
Ukraine
30
Ghana
27
Argentina
27
Mozambique
26
Paraguay
26
Indonesia
26
Lesotho
25
Russia
25
Namibia
25
Peru
23
Cambodia
23
Liberia
23
Sierra Leone
22
Asia
21
Philippines
19
Senegal
18
Venezuela
17
Bolivia
16
Zimbabwe
15
Brazil
14
El Salvador
13
Burkina Faso
13
South–East Asia Region
13
Botswana
13
Tajikistan
10
Cameroon
10
Haiti
10
East and Southern Africa
9
South Sudan
9
Ecuador
8
Benin
7
Chile
7
Syria
7
Albania
7
Congo, Democratic Republic of
7
Georgia
7
Eswatini/ Swaziland
7
Eastern Europe and Central Asia
6
North America
6
Thailand
5
China
5
Guinea
5
West and Central Africa
5
Middle East and North Africa
5
Yemen
5
Pakistan
5
Afghanistan
4
Uruguay
4
Vietnam
4
Moldova
4
Angola
4
Mexico
3
Estonia
3
Dominican Republic
3
Jordan
3
Western Pacific Region
3
Lebanon
3
Papua New Guinea
3
Nicaragua
3
Sri Lanka
3
Sudan
3
Central African Republic
3
Honduras
3
Chad
3
Guatemala
3
North Macedonia
2
Timor Leste/ East Timor
2
Togo
2
Iran
2
Laos
2
Morocco
2
Armenia
2
USA
2
Guinea-Bissau
2
Hungary
2
Saudi Arabia
2
Japan
2
Spain
2
Southern Africa
2
Poland
2
Mali
2
Somalia
2
Madagascar
2
North Korea
1
Switzerland
1
Gambia
1
Kyrgyzstan
1
Mongolia
1
Jamaica
1
Denmark
1
Tunisia
1
Norway
1
Portugal
1
Belize
1
Costa Rica
1
Panama
1
Romania
1
Greece
1
Palestine
1
Bhutan
1
Iraq
1
Solomon Islands
1
Authors & Publishers
Publication Years
Category
Countries
1115
Clinical Guidelines
241
Public Health
131
Key Resources
88
Women & Child Health
80
Pharmacy & Technologies
35
Capacity Building
31
Toolboxes
TB
717
HIV
398
COVID-19
142
AMR
109
NTDs
80
Mental Health
71
Health Financing Toolbox
67
NCDs
63
Pharmacy
54
Caregiver
52
Global Health Education
52
Planetary Health
45
Ebola & Marburg
41
Refugee
40
Rapid Response
32
Conflict
29
Disability
28
Malaria
27
Polio
27
Natural Hazards
18
2.0 Rapid Response
13
Cholera
2
Social Ethics
2
Zika
2
Specific Hazards
1
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-...
Las Infecciones Asociadas a la Atención en Salud (IAAS) son reconocidas en la
actualidad como un problema de salud pública y existen lineamientos guber-
namentales en la mayoría de los países para constituir sistemas de vigilancia y
Programas de Prevención y Control de Infecciones para con...
The strategic framework gives guidance to public and private health facilities and health workers on compliance with standards relating to IPC practices. To further assist health facilities to implement the IPC strategic framework, this practical implementation manual has been developed in parallel ...
This joint publication by UNAIDS and WHO emphasizes the importance of integrating HIV prevention, testing, treatment and care and mental health services for people living with HIV. It provides a compilation of tools, best practices, recommendations and guidelines that facilitate the integration of i...
The WHO COVID-19 Clinical management: living guidance contains the most up-to-date recommendations for the clinical management of people with COVID-19. Providing guidance that is comprehensive and holistic for the optimal care of COVID-19 patients throughout their entire illness is important.
To better adapt current case management practices and address excess mortality in otherwise treatable
cases will require better knowledge of the demographic characteristics of the patients and comorbidities
which can make severe dehydration harder to tolerate physiologically. With this in mind, a ...
The 6th edition of the essential medicine list has been developed based on the 5th edition list of essential medicines, the National Standard Treatment Guidelines and Protocols 2013, list of laboratory commodities and List of Consumables used in public health facilities.
Guidelines and Consensus for the Diagnosis, Management and Prevention of Type 2 Diabetes Mellitus in Indonesia
Module 4
Leaders
July 2017
Module 4: Leaders. This module aims to inform and update leaders and decision-makers about PrEP. It provides information on the benefits and limitations of PrEP so that they can consider how PrEP could be effectively implemented in their own settings. It also contai...
WHO’s Country Cooperation Strategy (CCS) defines the Organization’s medium-term vision for working in and with a particular country. The CCS, developed in the context of global and national health priorities, examines the overall health situation in a country, including the state of the health s...
Recommendations for a Public Health approach and considerations for policy-makers and managers
Technical specifications series for submission to WHO prequalification: diagnostic assessment;TSS-3
En este documento se ofrecen orientaciones a las autoridades de salud en todos los niveles para que mejoren la tasa de éxito de la localización de contactos al asegurarse de que las actividades correspondientes se sustenten en los principios, la evidencia y las actividades de CRPC, y se suministra...
Bonchial asthma is the most common chronic respiratory disease in the world. In Kenya, it has been estimated that about 7.5% of the Kenyan population, nearly 4 million people, are currently living with asthma. Many cases tend to be underdiagnosed and undertreated which leads to high levels of morbid...
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influenza A) viruses.
BUKO Pharma-Kampagne has investigated the causes and consequences of antibiotic resistance in India, South Africa, Tanzania and Germany. Together with our partners we collected data and did interviews with numerous stakeholders. The outcome is presented in a brochure that is now available in English...
